Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 151 AL 165

Herbal Therapeutics for Alzheimer's Disease: Ancient Indian Medicine System from the Modern Viewpoint

Kushwah S, Maurya NS, Kushwaha S, Scotti L, Chawade A, Mani A.

Curr Neuropharmacol. 2023;21(4):764-776. doi: 10.2174/1570159X21666230216094353.

Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor: A phase I study in healthy young and elderly Chinese subjects

Qian H, Yu C, Zhu H, Ding Q, Cai Y, Jing J, Xu X, Guo R, Zhang H, Liu H, Chen X, Liu Y.

Clin Transl Sci. 2023 May;16(5):810-822. doi: 10.1111/cts.13490. Epub 2023 Feb 26.

How Single Site Mutations Can Help Understanding Structure Formation of Amyloid β(1-40)

Schwarze B, Huster D.

Macromol Biosci. 2023 May;23(5):e2200489. doi: 10.1002/mabi.202200489. Epub 2023 Mar 10.

The β-adrenergic hypothesis of synaptic and microglial impairment in Alzheimer's disease

Li S.

J Neurochem. 2023 May;165(3):289-302. doi: 10.1111/jnc.15782. Epub 2023 Feb 28.

Extemporaneous combination of donepezil and memantine to treat dementia in Alzheimer disease: evidence from Italian real-world data

Padovani A, Falato S, Pegoraro V.

Curr Med Res Opin. 2023 Apr;39(4):567-577. doi: 10.1080/03007995.2023.2182530. Epub 2023 Mar 11.

Research progress of natural products and their derivatives against Alzheimer's disease

Liu JY, Guo HY, Quan ZS, Shen QK, Cui H, Li X.

J Enzyme Inhib Med Chem. 2023 Dec;38(1):2171026. doi: 10.1080/14756366.2023.2171026.

Lessons from antiamyloid-β immunotherapies in Alzheimer's disease

Plascencia-Villa G, Perry G.

Handb Clin Neurol. 2023;193:267-292. doi: 10.1016/B978-0-323-85555-6.00019-9.

Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease

Gueorguieva I, Willis BA, Chua L, Chow K, Ernest CS, Shcherbinin S, Ardayfio P, Mullins GR, Sims JR.

Clin Pharmacol Ther. 2023 Jun;113(6):1258-1267. doi: 10.1002/cpt.2875. Epub 2023 Mar 9.

The Alzheimer's Disease Mitochondrial Cascade Hypothesis: A Current Overview

Swerdlow RH.

J Alzheimers Dis. 2023;92(3):751-768. doi: 10.3233/JAD-221286.

Peptide Self-Assembly into Amyloid Fibrils at Hard and Soft Interfaces-From Corona Formation to Membrane Activity

John T, Martin LL, Abel B.

Macromol Biosci. 2023 Jun;23(6):e2200576. doi: 10.1002/mabi.202200576. Epub 2023 Mar 10.

Aberrant protein S-nitrosylation contributes to hyperexcitability-induced synaptic damage in Alzheimer's disease: Mechanistic insights and potential therapies

Ghatak S, Nakamura T, Lipton SA.

Front Neural Circuits. 2023 Feb 2;17:1099467. doi: 10.3389/fncir.2023.1099467. eCollection 2023.

Soluble and insoluble protein aggregates, endoplasmic reticulum stress, and vascular dysfunction in Alzheimer's disease and cardiovascular diseases

Waigi EW, Webb RC, Moss MA, Uline MJ, McCarthy CG, Wenceslau CF.

Geroscience. 2023 Jun;45(3):1411-1438. doi: 10.1007/s11357-023-00748-y. Epub 2023 Feb 24.

Spontaneous intracerebral haemorrhage associated with early-onset cerebral amyloid angiopathy and Alzheimer's disease neuropathological changes five decades after cadaveric dura mater graft

Milani R, Mazzeo LA, Vismara D, Salemi I, Dainese E, Maderna E, Pellencin E, Catania M, Campanella N, Di Fede G, Giaccone G, Salmaggi A.

Acta Neuropathol Commun. 2023 Feb 24;11(1):30. doi: 10.1186/s40478-023-01528-7.

The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET

Mohammadi Z, Alizadeh H, Marton J, Cumming P.

Biomolecules. 2023 Feb 3;13(2):290. doi: 10.3390/biom13020290.

Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders

Nirogi R, Jayarajan P, Shinde A, Mohammed AR, Grandhi VR, Benade V, Goyal VK, Abraham R, Jasti V, Cummings J.

Biomolecules. 2023 Feb 7;13(2):309. doi: 10.3390/biom13020309.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias